Optimizing Treatment Outcomes in Advanced NSCLC with Concurrent Biomarker Testing - Episode 1

Optimizing NSCLC Patient Outcomes Through Concurrent Biomarker Testing

,

Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, emphasize the crucial role of molecular testing in disease diagnosis, focusing on the significance of rapid turnaround times and the ability of liquid biopsies to address time-sensitive diagnostic needs.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: Optimizing NSCLC Patient Outcomes Through Concurrent Biomarker Testing
    EP. 2: Concurrent NSCLC Biomarker Testing at Diagnosis
    EP. 3: NCCN Guidelines: Optimizing NSCLC Treatment with Concurrent Biomarker Testing
    EP. 4: Improving Time-to-Treatment for Patients With Non-Small Cell Lung Cancer
    EP. 5: Biomarker Testing in Early-Stage NSCLC
    EP. 6: Reflex Testing for Patients with Suspected Lung Cancer
    EP. 7: Challenges of NSCLC Biomarker Testing in Clinical Practice
    EP. 8: Overcoming Barriers to NSCLC Biomarker Testing
    EP. 9: Key Takeaways for Concurrent Biomarker Testing in NSCLC
    x